Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With

Clinical Trial Summary

To determine the time to and rate of hematologic engraftment following unrelated umbilical cord blood transplantation in adults with one or two cord blood units using total body irradiation and fludarabine as the transplant conditioning regimen and cyclosporine/MMF as graft-versus-host disease prophylaxis.

See also
Status	Clinical Trial	Phase
Completed	`NCT04932967` - Use of nMoABs for the Treatment of COVID-19 in Patients With HM.
Not yet recruiting	`NCT02900768` - Effects of Exercise on Allogeneic Stem Cell Transplant	N/A
Recruiting	`NCT04082910` - Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells	Phase 1/Phase 2
Recruiting	`NCT05510089` - Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies	N/A
Terminated	`NCT04093622` - Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy
Recruiting	`NCT06106360` - A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
Recruiting	`NCT06225856` - An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies	Phase 1
Recruiting	`NCT02828462` - Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
Completed	`NCT01714180` - Effect of Body Mass on Acyclovir Pharmacokinetics	N/A
Completed	`NCT03241550` - A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients	Phase 1
Active, not recruiting	`NCT04684108` - SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies	Phase 1
Completed	`NCT02598752` - Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
Completed	`NCT02880709` - The Effect of Special Diets in Hematological Cancer Patients	Phase 4
Completed	`NCT00894049` - A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation	Phase 2
Completed	`NCT04687982` - Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).	N/A
Recruiting	`NCT03850366` - HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib	Phase 2
Not yet recruiting	`NCT06066255` - PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM	Phase 2
Enrolling by invitation	`NCT05364359` - Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy	N/A
Recruiting	`NCT04841447` - Membrane Target Detection for Leukemia Treatment
Not yet recruiting	`NCT06224452` - Is Ibrutinib-related Atrial Fibrillation Dose Dependent

NCT number	NCT00897260
Study type	Interventional
Source	University of British Columbia
Contact
Status	Completed
Phase	N/A
Start date	May 2009
Completion date	January 9, 2013

Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms